GramEye Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.72M
- Investors
-
11
GramEye General Information
Description
Developer of medical devices designed to automate Gram staining using deep learning and robotics. The company develops a system that automates, speeds up, and digitizes the Gram staining process using unique technology, enabling doctors to properly prescribe antibiotics in medical settings around the world.
Contact Information
Website
grameye.comCorporate Office
- Nature Ibaraki 4th Floor
- Ekimae 3-7-1
- Ibaraki, Osaka 567-0888
- Japan
Corporate Office
- Nature Ibaraki 4th Floor
- Ekimae 3-7-1
- Ibaraki, Osaka 567-0888
- Japan
GramEye Timeline
GramEye Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 20-Nov-2025 | $2.72M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 20-Nov-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 04-Sep-2025 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 13-Oct-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Mar-2022 | $434K | $434K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Apr-2021 | Completed | Startup |
GramEye Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class C | ||||||||
| Class B | ||||||||
| Class AA | 750 | $130.06 | $130.06 | 1x | $130.06 | 3.94% | ||
| Class A | 1,030 | $220.78 | $220.78 | 1x | $220.78 | 5.41% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GramEye Patents
GramEye Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026071259-A1 | Information processing device and system | Pending | 30-Sep-2024 | ||
| WO-2026009852-A1 | Microscope slide and staining method | Pending | 02-Jul-2024 | ||
| JP-2026032265-A | Slide glass and staining method | Pending | 02-Jul-2024 | ||
| JP-7790807-B1 | Slides and staining methods | Active | 02-Jul-2024 | ||
| JP-7723425-B2 | Automatic dye substance estimation system | Active | 12-Nov-2020 |
GramEye Signals
GramEye Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beyond Next Ventures | Venture Capital | Minority | ||
| Japan External Trade Organization | Accelerator/Incubator | |||
| NES Venture Capital | Corporate Venture Capital | Minority | ||
| Senshu Ikeda Capital | Venture Capital | Minority | ||
| SMBC Venture Capital | Corporate Venture Capital | Minority |
GramEye FAQs
-
When was GramEye founded?
GramEye was founded in 2020.
-
Where is GramEye headquartered?
GramEye is headquartered in Ibaraki, Japan.
-
What is the size of GramEye?
GramEye has 26 total employees.
-
What industry is GramEye in?
GramEye’s primary industry is Other Devices and Supplies.
-
Is GramEye a private or public company?
GramEye is a Private company.
-
What is GramEye’s current revenue?
The current revenue for GramEye is .
-
How much funding has GramEye raised over time?
GramEye has raised $6.56M.
-
Who are GramEye’s investors?
Beyond Next Ventures, Japan External Trade Organization, NES Venture Capital, Senshu Ikeda Capital, and SMBC Venture Capital are 5 of 11 investors who have invested in GramEye.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process